The fourth international CDDR (Centre for Drug Delivery Research) conference was held at the School of Pharmacy, University of London, UK in December last year (Organisers: Gregory Gregoriadis and Alexander Florence, School of Pharmacy). The purpose of this meeting was to cover recent progress and trends in the use of liposomes (and other lipid-based systems) in drug and vaccine delivery and targeting. Topics covered included cancer treatment, lipoplex assembly and structure, DNA vaccines, and lipid-based vaccines. The presentations related to gene therapy are discussed in this brief report.
Several groups discussed the delivery of antisense oligonucleotides (AS-ODN) encapsulated in cationic liposomes. Rahman and co-workers (Georgetown University, Washington, DC, USA) presented a study where AS-ODN were used to inhibit Raf-1 protein expression in the relatively radioresistant laryngeal squamous carcinoma cell line SQ-20B. Raf-1 is a protein kinase important in cell growth, proliferation and survival. Its overexpression or activation is associated with in vitro resistance. In vitro data showed 13% uptake of an AS-ODN against the translation initiator region (ATG-ODN) over 24 h and there was a 10-fold advantage over free ODN when encapsulated in liposomes. Raf-1 protein expression was inhibited with the maximal effect at 8 h. In a SQ-20B tumour model, delivery of ATG-ODN resulted in a reduction in tumour volume to one third the size of the control group after 60 days. The combination of AS-ODN and ionising radiation led to significant tumour regression. This was due to apoptosis. Ponzoni and coworkers (Giannina Gaslinin Institute, Italy) discussed the application of AS-ODNs to treat advanced stage neuroblastoma. AS-ODNs targeted to the c-myb oncogene were encapsulated in long-circulating anti-GD2-targeted immunoliposomes. Uptake into human NB cells in vitro was specific with a four-to five-fold increase in AS-ODN uptake in GD2-positive cells compared with GD2-negative cells. Also, this uptake was five to 10 higher compared with free AS-ODN or AS-ODN encapsulated in non-targeted liposomes. Reduced levels of c-myb protein were noted and complete inhibition of cell proliferation.
Gene delivery to embryonic tissue
Longmuir and co-workers (University of California, CA, USA) have developed a liposomal complex for gene delivery which produces high levels of gene expression in vitro and in chicken embryos. This novel complex has three functional parts: a nuclear localisation signal peptide fused to a lipid; a fusogenic peptide comprised of the membrane insertion and amphipathic helical segments of the N-terminal domain of human pulmonary protein B; and polyethyleneglycol or transferrin to provide steric stability.
Strategies to overcome the barriers associated with systemic delivery of lipoplexes
Marshall and co-workers (Genzyme, MA, USA) described a series of novel cationic lipids which were more effective in gene transfer following intravenous delivery of lipoplexes. Coupling of a polycationic head group to the lipophilic moiety through a primary rather than a secondary amine resulted in a 10-fold increase in transgene expression. Another 10-fold increase in transfection efficiency was achieved when the cationic amines were formulated as free bases rather than protonated. Substitution of the commonly used 'neutral lipid' DOPE with diphytanoylphosphatidylethanolamine significantly increased transfection. Improvements in transgene expression and toxicity profiles were attained when the complexes were infused slowly rather than given as a bolus.
BOLAsomes: a novel self-assembly vector for targeted gene delivery Turner and co-workers (Celltech Chiroscience, UK) have developed a novel gene delivery vector called a BOLAsome. This new vector contains a novel bi-polar amphiphile (BOLA) comprising of three components: a T-shaped polyamine with six positive charges for DNA compaction; a 24-carbon chain providing a protective hydrophobic layer around the DNA; and a water soluble headgroup, either a sugar moiety or PEG. BOLA is combined with DNA in a single step aqueous event resulting in the self-assembly of small particles which are serum stable and display a low level of non-specific binding.
